Cancer Communications is a platform for collaboration on basic, clinical, and translational cancer research. Proudly open access - every issue is accessible to the world.

Our oncology journal welcomes submissions spanning clinical trials, epidemiology, molecular and cellular biology, and genetics.

Journal Metrics

  • 36.5CiteScore
  • 24.9Journal Impact Factor
  • 7%Acceptance rate
  • 11 days Submission to first decision
view all metrics

On the Cover

Skip slideshow
The cover image is based on the Original Article Lung cancer risk score for ever and never smokers in China by Zhimin Ma et al., https://doi.org/10.1002/cac2.12463.
The cover image is based on the Original Article Perivascular localized cells commit erythropoiesis in PDGF-B-expressing solid tumors by Kayoko Hosaka et al., https://doi.org/10.1002/cac2.12423.
The cover image is based on the Correspondence Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer by Stephen Keelan et al., https://doi.org/10.1002/cac2.12407.
The cover image is based on the Original Article Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors by Hiroyuki Suzuki et al., https://doi.org/10.1002/cac2.12411.
The cover image is based on the Research Article PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression by Hong-Yong Cui et al., https://doi.org/10.1002/cac2.12322.
The cover image is based on the Review Article-The Theory of Tumor Ecosystem by Xueman Chen et al., https://doi.org/10.1002/cac2.12316.
The cover image is based on the Review Article Epi-immunotherapy for cancers by Wenbin Qian et al., https://doi.org/10.1002/cac2.12313.
The cover image is based on the Letter to Editor Proteomic identification of new diagnostic biomarkers of early-stage cutaneous mycosis fungoides by Yukun Wang et al., https://doi.org/10.1002/cac2.12266.
The cover image is based on the Research Article The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China by Huaxia Yang et al., https://doi.org/10.1002/cac2.12283.

Featured Information

Skip slideshow

Why publish in Cancer Communications?

  • Save time formatting your manuscript with free formatting submission.
  • Your research will be open access, making it freely available to read, download and share with ease.
  • Quality and impactful research governed by an international and distinguished editorial board.
  • Your work will be discoverable and widely distributed with indexing by MEDLINE, PubMed, PubMed Central, SCIE, Scopus and Directory of Open Access Journals.

Get the latest research with personalized alert


Create a FREE Wiley Online Library account and register to receive Content Alerts and instant notifications when research publishes in Cancer Communications.

  • Receive personalized alerts at a pace that suits you.
  • Keep track of a paper of interest with citation alerts.
  • Save content to easily manage your reading list.
  • Save searches for instant review later.

Register here

Aim & Scope

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.

 

Meet the Editor-in-Chief

Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Vice president of China Anti-cancer Association (CACA)
President-Elect of Chinese Society of Clinical Oncology (CSCO)
Director of State Key Laboratory of Oncology in South China
Chairman of Committee of targeted therapy in Oncology, Chinese Anti-Cancer Association
President of Sun Yat-sen University Cancer Center, China

Articles

ORIGINAL ARTICLE
Open access

Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti‐PD‐1 immunotherapy efficacy in colorectal cancer liver metastasis

Yizhi Zhan, Jinsong Xu, Zhanqiao Zhang, Yating Hu, Yongsheng Li, Junying Qian, Yunyan Ling, Dehua Wu, Haijun Deng, Guoxin Li, Zhiyong Shen, Yuan Fang, 
  •  16 July 2025
LETTER TO THE JOURNAL
Open access

Comparative single‐cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses

Seungbyn Baek, Junha Cha, Min Hee Hong, Gamin Kim, Yoon Woo Koh, Dahee Kim, Wonrak Son, Chan-Young Ock, Seungeun Lee, Martin Hemberg, Seong Yong Park, Hye Ryun Kim, Insuk Lee, 
  •  28 June 2025
LETTER TO THE JOURNAL
Open access

A serum exosomal microRNA‐based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinoma

Jin-Seong Hwang, Sugi Lee, Gyeonghwa Kim, Hoibin Jeong, Kiyoon Kwon, Eunsun Jung, Yuna Roh, Taesang Son, Hana Lee, Moo-Seung Lee, Kyoung-Jin Oh, Hye Won Lee, Yu Rim Lee, Soo Young Park, Won Young Tak, Hyun Seung Ban, Hyun-Soo Cho, Mi-Young Son, Jang-Seong Kim, Keun Hur, Dae-Soo Kim, Tae-Su Han, 
  •  26 June 2025
FEATURED COVER
Open access

Cover Image, Volume 45, Issue 6

Katia Mariniello, James F. H. Pittaway, Barbara Altieri, Kleiton Silva Borges, Irene Hadjidemetriou, Claudio Ribeiro, Gerard Ruiz-Babot, David S. Tourigny, Jiang A. Lim, Julie Foster, Julie Cleaver, Jane Sosabowski, Nafis Rahman, Milena Doroszko, Constanze Hantel, Sandra Sigala, Andrea Abate, Mariangela Tamburello, Katja Kiseljak-Vassiliades, Margaret Wierman, Charlotte Hall, Laila Parvanta, Tarek E. Abdel-Aziz, Teng-Teng Chung, Aimee Di Marco, Fausto Palazzo, Celso E. Gomez-Sanchez, David R. Taylor, Oliver Rayner, Cristina L. Ronchi, Carles Gaston-Massuet, Silviu Sbiera, William M. Drake, Emanuel Rognoni, Matthias Kroiss, David T. Breault, Martin Fassnacht, Leonardo Guasti, 
  •  24 June 2025

Abstract

The cover image is based on the article Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma by James Pittaway et al., https://doi.org/10.1002/cac2.70012.

image

ORIGINAL ARTICLE
Open access

NAT10 regulates tumor progression and immune microenvironment in pancreatic ductal adenocarcinoma via the N4‐acetylated LAMB3‐mediated FAK/ERK pathway

Enhong Chen, Qin Wang, Leisheng Wang, Zebo Huang, Dongjie Yang, Changyong Zhao, Wuqiang Chen, Shuo Zhang, Shuming Xiong, Youzhao He, Yong Mao, Hao Hu, 
  •  20 June 2025
More articles

Articles with the most citations published in the Last 2 Years according to CrossRef. The citation counts listed reflect the total number of all citations to date.

Open access

Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma

Jialiang Cai, Lina Song, Feng Zhang, Suiyi Wu, Guiqi Zhu, Peiling Zhang, Shiping Chen, Junxian Du, Biao Wang, Yufan Cai, Yi Yang, Jinglei Wan, Jian Zhou, Jia Fan, Zhi Dai, 
Open access

Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment

Fusheng Zhang, Junchen Guo, Shengmiao Yu, Youwei Zheng, Meiqi Duan, Liang Zhao, Yihan Wang, Zhi Yang, Xiaofeng Jiang, 
Open access

Altered glycosylation in cancer: molecular functions and therapeutic potential

Xuemeng Xu, Qiu Peng, Xianjie Jiang, Shiming Tan, Wenjuan Yang, Yaqian Han, Linda Oyang, Jinguan Lin, Mengzhou Shen, Jiewen Wang, Haofan Li, Longzheng Xia, Mingjing Peng, Nayiyuan Wu, Yanyan Tang, Hui Wang, Qianjin Liao, Yujuan Zhou, 
Open access

The regulatory roles and clinical significance of glycolysis in tumor

Qiqi Qiao, Shunfeng Hu, Xin Wang, 
Open access

Cancer situation in China: an analysis based on the global epidemiological data released in 2024

Xiayao Diao, Chao Guo, Yukai Jin, Bowen Li, Xuehan Gao, Xin Du, Zhenchong Chen, Minju Jo, Yi Zeng, Chao Ding, Wenwu Liu, Jianrong Guo, Shanqing Li, Haibo Qiu, 
Open access

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy

Jie Chen, Yuhang Duan, Junye Che, Jianwei Zhu, 
Open access

Exposure of benzo[a]pyrene induces HCC exosome‐circular RNA to activate lung fibroblasts and trigger organotropic metastasis

Wei Mu, Pengfei Gu, Huating Li, Jinjin Zhou, Yulun Jian, Weiping Jia, Yang Ge, 
Open access

Disitamab vedotin, a HER2‐directed antibody‐drug conjugate, in patients with HER2‐overexpression and HER2‐low advanced breast cancer: a phase I/Ib study

Jiayu Wang, Yunjiang Liu, Qingyuan Zhang, Wei Li, Jifeng Feng, Xiaojia Wang, Jianmin Fang, Yiqun Han, Binghe Xu, 
More articles

Recent issues

Latest news

More news >